• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Incidence and Mortality Patterns of Acute Myeloid Leukemia in Belgrade, Serbia (1999⁻2013).塞尔维亚贝尔格莱德地区急性髓系白血病的发病率和死亡率模式(1999 年至 2013 年)。
Medicina (Kaunas). 2018 Mar 20;54(1):5. doi: 10.3390/medicina54010005.
2
Trends and patterns of ovarian cancer mortality in Belgrade, Serbia: a joinpoint regression analysis.塞尔维亚贝尔格莱德卵巢癌死亡率的趋势和模式:一个联合回归分析。
Int J Gynecol Cancer. 2011 Aug;21(6):1018-23. doi: 10.1097/IGC.0b013e31821dc8d1.
3
Suicide in Serbia.塞尔维亚的自杀情况。
J Affect Disord. 2016 Mar 15;193:187-93. doi: 10.1016/j.jad.2015.12.063. Epub 2016 Jan 5.
4
[Analysis of mortality in cancer of the large intestine in a cohort group in Serbia from 1971 to 1996].[1971年至1996年塞尔维亚队列组中大肠癌死亡率分析]
Srp Arh Celok Lek. 2002 May-Jun;130(5-6):173-7. doi: 10.2298/sarh0206173g.
5
[Mortality from heart attack in Belgrade population during the period 1990-2004].[1990年至2004年期间贝尔格莱德人群中心肌梗死死亡率]
Srp Arh Celok Lek. 2008 Nov-Dec;136(11-12):598-602. doi: 10.2298/sarh0812598r.
6
[Oesophageal-cancer-derived death in the population of Belgrade in a period 1989-2006].[1989年至2006年期间贝尔格莱德人群中食管癌导致的死亡情况]
Vojnosanit Pregl. 2009 Jul;66(7):534-8. doi: 10.2298/vsp0907534j.
7
Incidence and mortality trends of ovarian cancer in central Serbia.塞尔维亚中部卵巢癌的发病率和死亡率趋势
J BUON. 2017 Mar-Apr;22(2):508-512.
8
The rising incidence and mortality of prostate cancer in Belgrade population.贝尔格莱德人群中前列腺癌发病率和死亡率的上升。
Coll Antropol. 2011 Jun;35(2):499-503.
9
Italian cancer figures, report 2012: Cancer in children and adolescents.《2012年意大利癌症数据报告:儿童和青少年癌症》
Epidemiol Prev. 2013 Jan-Feb;37(1 Suppl 1):1-225.
10
Mortality from cervical cancer in Serbia in the period 1991-2011.1991年至2011年期间塞尔维亚宫颈癌死亡率。
J BUON. 2015 Jan-Feb;20(1):231-4.

引用本文的文献

1
Understanding the causes of high mortality among adult acute leukaemia patients in Armenia.了解亚美尼亚成年急性白血病患者高死亡率的原因。
Ecancermedicalscience. 2025 Jul 23;19:1952. doi: 10.3332/ecancer.2025.1952. eCollection 2025.
2
Pretreatment expression of miR-191a may predict response to the induction chemotherapy based on cytarabine in acute myeloid leukemia patients - a single-center pilotal study.miR-191a的预处理表达可能预测急性髓系白血病患者基于阿糖胞苷的诱导化疗反应——一项单中心初步研究。
PLoS One. 2025 Jun 24;20(6):e0324320. doi: 10.1371/journal.pone.0324320. eCollection 2025.
3
Economic Burden of Acute Myeloid Leukemia in European Union: Results from a Systematic Review of Literature.欧盟急性髓系白血病的经济负担:文献系统综述结果
Pharmacoecon Open. 2025 May;9(3):365-378. doi: 10.1007/s41669-024-00554-y. Epub 2025 Apr 1.
4
Anti-IL-1RAP scFv-mSA-S19-TAT fusion carrier as a multifunctional platform for versatile delivery of biotinylated payloads to myeloid leukemia cells.抗白细胞介素 1 受体相关蛋白单链抗体-mSA-S19-TAT 融合载体作为一种多功能平台,可将生物素化有效载荷递送至髓系白血病细胞。
Sci Rep. 2024 Oct 23;14(1):25080. doi: 10.1038/s41598-024-76851-7.
5
Conjugation of TLR7 Agonist Combined with Demethylation Treatment Improves Whole-Cell Tumor Vaccine Potency in Acute Myeloid Leukemia.TLR7 激动剂缀合去甲基化治疗增强急性髓系白血病全细胞肿瘤疫苗效力。
Int J Med Sci. 2020 Aug 27;17(15):2346-2356. doi: 10.7150/ijms.49983. eCollection 2020.
6
The European Medicines Agency Review of Gilteritinib (Xospata) for the Treatment of Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia with an FLT3 Mutation.欧洲药品管理局审查吉特替尼(Xospata)用于治疗伴有 FLT3 突变的复发性或难治性成人急性髓系白血病。
Oncologist. 2020 Jul;25(7):e1070-e1076. doi: 10.1634/theoncologist.2019-0976. Epub 2020 Mar 10.

本文引用的文献

1
Trends in hematological cancer in the elderly in Denmark, 1980-2012.1980 - 2012年丹麦老年人血液系统癌症的发病趋势
Acta Oncol. 2016;55 Suppl 1:98-107. doi: 10.3109/0284186X.2015.1115124. Epub 2016 Jan 19.
2
Acute Myeloid Leukemia.急性髓系白血病
N Engl J Med. 2015 Sep 17;373(12):1136-52. doi: 10.1056/NEJMra1406184.
3
Trends in mortality of adult patients diagnosed with myeloid leukemia from 1994 to 2011 in southeastern Brazil.1994年至2011年巴西东南部成年髓系白血病患者的死亡率趋势。
Rev Bras Hematol Hemoter. 2015 Jan-Feb;37(1):7-11. doi: 10.1016/j.bjhh.2014.11.011. Epub 2014 Nov 21.
4
Acute myeloblastic leukaemias in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.成年患者急性髓系白血病:ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2013 Oct;24 Suppl 6:vi138-43. doi: 10.1093/annonc/mdt320. Epub 2013 Aug 22.
5
Survival and cure of acute myeloid leukaemia in England, 1971-2006: a population-based study.1971-2006 年英格兰急性髓细胞白血病的生存和治愈情况:一项基于人群的研究。
Br J Haematol. 2013 Aug;162(4):509-16. doi: 10.1111/bjh.12425. Epub 2013 Jun 21.
6
Incidence, survival and prevalence of myeloid malignancies in Europe.欧洲髓系恶性肿瘤的发病率、生存率和流行率。
Eur J Cancer. 2012 Nov;48(17):3257-66. doi: 10.1016/j.ejca.2012.05.024. Epub 2012 Jul 4.
7
Incidence and mortality trends of leukemia and lymphoma in Croatia, 1988-2009.1988 - 2009年克罗地亚白血病和淋巴瘤的发病率及死亡率趋势
Croat Med J. 2012 Apr;53(2):115-23. doi: 10.3325/cmj.2012.53.115.
8
Acute myeloid leukemia in the real world: why population-based registries are needed.真实世界中的急性髓细胞白血病:为什么需要基于人群的登记处。
Blood. 2012 Apr 26;119(17):3890-9. doi: 10.1182/blood-2011-12-379008. Epub 2012 Mar 1.
9
Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007.美国 2001-2007 年儿童和成人急性白血病发病和患者生存情况。
Blood. 2012 Jan 5;119(1):34-43. doi: 10.1182/blood-2011-04-347872. Epub 2011 Nov 15.
10
Therapeutic advances in acute myeloid leukemia.急性髓细胞白血病的治疗进展。
J Clin Oncol. 2011 Feb 10;29(5):487-94. doi: 10.1200/JCO.2010.30.1820. Epub 2011 Jan 10.

塞尔维亚贝尔格莱德地区急性髓系白血病的发病率和死亡率模式(1999 年至 2013 年)。

Incidence and Mortality Patterns of Acute Myeloid Leukemia in Belgrade, Serbia (1999⁻2013).

机构信息

Institute of Epidemiology, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.

Institute of Medical Statistics and Informatics, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.

出版信息

Medicina (Kaunas). 2018 Mar 20;54(1):5. doi: 10.3390/medicina54010005.

DOI:10.3390/medicina54010005
PMID:30344236
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6037239/
Abstract

: To assess incidence and mortality trends of acute myeloid leukemia (AML) in Belgrade (Serbia) in a 15-year period (from 1999 to 2013). Data were obtained from the Cancer Registry of Serbia, Institute of Public Health of Serbia. Standardized incidence and mortality rates per 100,000 inhabitants were calculated by direct standardization method using World Standard Population. Analysis of raw data indicated single-digit numbers per year and per 5-year age cohorts. Therefore, we merged years of diagnosis to three-year intervals, creating so-called "moving averages". We also merged study population to 10-year age cohorts. Both incidence and mortality rates increased with age, i.e., the lowest rates were observed in the youngest age groups and the highest rates were observed in oldest age groups. In all age groups, except the youngest (15⁻24 years), AML incidence was statistically significantly higher in men compared with women. Average age-adjusted incidence was 2.73/100,000 (95% confidence interval (CI) 2.28⁻3.71). Average age-adjusted mortality was 1.81/100,000 (95% CI 1.30⁻2.26). Overall, there were no significant changes in incidence trend. Age-adjusted incidence rates had increasing tendency among men aged 65⁻74 years (B = 0.80, standard error (SE) = 0.11; = 0.005) and in total population aged 65⁻74 years (B = 0.41, SE = 0.09; = 0.023). Increasing tendency in incidence of AML among women was observed in age group >75 years (B = 0.63, SE = 0.14; = 0.019). No changes of mortality trend were observed. There was no significant change in trends of AML from 1999 to 2013 in the population of Belgrade.

摘要

: 评估 15 年间(1999 年至 2013 年)在贝尔格莱德(塞尔维亚)急性髓系白血病(AML)的发病率和死亡率趋势。数据来自塞尔维亚癌症登记处和塞尔维亚公共卫生研究所。采用世界标准人口直接标准化法计算每 10 万人的标准化发病率和死亡率。原始数据分析表明,每年和每 5 岁年龄组的数字都为个位数。因此,我们将诊断年份合并为三年间隔,创建所谓的“移动平均值”。我们还将研究人群合并为 10 岁年龄组。发病率和死亡率均随年龄增长而增加,即最低发病率见于最年轻的年龄组,最高见于最年长的年龄组。除了最年轻的年龄组(15-24 岁)外,所有年龄组中男性 AML 的发病率均显著高于女性。平均年龄调整发病率为 2.73/100,000(95%置信区间(CI)2.28-3.71)。平均年龄调整死亡率为 1.81/100,000(95%CI 1.30-2.26)。总体而言,发病率趋势没有明显变化。年龄调整后的发病率在 65-74 岁的男性中呈上升趋势(B = 0.80,标准误差(SE)= 0.11; = 0.005)和 65-74 岁的总人口中呈上升趋势(B = 0.41,SE = 0.09; = 0.023)。在年龄组 >75 岁的女性中,AML 的发病率呈上升趋势(B = 0.63,SE = 0.14; = 0.019)。死亡率趋势没有变化。1999 年至 2013 年期间,贝尔格莱德人群中 AML 的发病趋势没有明显变化。